TrKA-R expression, required for NGF signalling, was observed to be significantly reduced in the parietal cortex of AD patients [66], and the neurotrophin has been suggested to undergo degradation during both pre-clinical and clinical stages of AD [67]. Here, NGF is linked to Alzheimer disease.